Greenwood Shines Spotlight on Insurance Industry Rip-off

Writing for The Hill, BIO’s President and CEO Jim Greenwood shined a spotlight on a shocking Wall Street Journal investigation showing how health insurance companies in the U.S. dramatically inflated their cost projections under Medicare Part D for financial gain over a 10 year period:
“Under peculiar language of the statute, insurers are paid by Medicare for drugs in advance of their purchase, based on their own estimated outlays. However, they only have to repay a portion